Literature DB >> 1945742

The role of medicinal chemistry in drug research.

W Soudijn1.   

Abstract

Classical medicinal chemistry, that is molecular modifications of existing bioactive compounds, leading to me-too drugs with value added and often to me-too drugs which will never reach the market or to drugs in another pharmacological field than that originally intended, will be with us for a long time to come. The ultimate goal, however, is of course rational or at least semi-rational drug design. In some instances this goal seems to have already been reached as in the case of angiotensin-converting enzyme inhibitors and H2 antagonists. In the (near) future results from the steady progress in molecular biology in combination with computer-assisted drug modelling--possibly coupled with artificial intelligence techniques--will help the medicinal chemist in his efforts to attain this goal.

Mesh:

Year:  1991        PMID: 1945742     DOI: 10.1007/bf01957740

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  7 in total

1.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

Review 2.  From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.

Authors:  G J Sanger; F D King
Journal:  Drug Des Deliv       Date:  1988-12

3.  WIZARD: AI in conformational analysis.

Authors:  D P Dolata; A R Leach; K Prout
Journal:  J Comput Aided Mol Des       Date:  1987-04       Impact factor: 3.686

4.  Angiotensin converting enzyme inhibitors.

Authors:  W Soudijn
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

5.  SUBSTITUTED 2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONES AND 3,4-DIHYDRO-2-PHENYL-(2H)-1,6-BENZOTHIAZOCIN-5(6H)-ONES.

Authors:  J KRAPCHO; E R SPITZMILLER; C F TURK
Journal:  J Med Chem       Date:  1963-09       Impact factor: 7.446

6.  Effects of tertatolol in hypertensive patients with chronic renal failure.

Authors:  M Beaufils; B Lantz; F Paillard; G Richet
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

7.  Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.

Authors:  A Salvetti; G Leonetti; G P Bernini; L Rupoli; A R Lucarini; P Sangiorgio; M Mauro; P Di Stratis; A Zanchetti
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.